MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

In Silico Electrophysiology and System Pharmacology Reveal Coupling Between Dopamine Receptors and Ca2+ Channels in Subthalamic Neuronal Cells towards Parkinson’s Disease

C. Mahapatra (Mumbai, India)

Meeting: 2024 International Congress

Abstract Number: 808

Keywords: Dopamine agonists, Dopamine receptor, Parkinson’s

Category: Parkinson’s Disease: Pharmacology and Therapy

Objective: Recent experimental evidence suggests a potential interaction between dopamine D2 receptors (D2R) and N-type Ca2+ channels, impacting the firing patterns of Subthalamic neuronal (STN) cells within the basal ganglia [1]. This in silico study aims to elucidate the underlying mechanisms of this interaction and its effects on resting membrane potential (RMP) and firing patterns dynamics in Parkinson’s Disease (PD).

Background: Parkinson’s Disease pathogenesis involves dopamine levels, dopamine receptors, and STN cell electrical activity.

Method: The study employs a three-fold quantitative model approach. Firstly, biophysical parameters for various ion channels in STN cells are integrated from previous research. Secondly, equations for the GPCR pathway are developed to modulate cAMP concentration, linked with N-type Ca2+ channel conductance. Finally, various pharmacological agents are simulated to explore novel biological insights.

Results: Using the dopamine receptor agonist Bromocriptine (Bromo) at 10 µM, the study investigates altered kinetics of N-type Ca2+ channels and subsequent firing patterns. Results revealed that Bromo modulates N-type Ca2+ channel activation curves, shifting the half activation potential of N-type Ca2+ channels to the more positive side. Dopamine agonists decrease AP frequency, attributed to reduced window current due to D2R activation and decreased N-type K+ channel conductance. Figure 1 illustrates the effects of a dopamine agonist on the simulated firing patterns with a current injection of 100 pA for a duration of 1 ms. It clearly shows the reduced firing frequency (blue solid line) under the effects of the dopamine agonists. The window current to maintain the RMP was reduced because of the activation of D2R receptors and it was counterbalanced by decreasing the K+ channel conductance.

Conclusion: The study suggests potential therapeutic strategies involving K+ channel agonists for PD treatment, potentially replacing dopamine in certain pathological conditions and enhancing spatial memory performance.

Figure 1 Modulating effects of dopamine agonist

Figure 1 Modulating effects of dopamine agonist

References: 1. Ramanathan, S., Tkatch, T., Atherton, J. F., Wilson, C. J., & Bevan, M. D. (2008). D2-like dopamine receptors modulate SKCa channel function in subthalamic nucleus neurons
through inhibition of Cav2. 2 channels. Journal of neurophysiology, 99(2), 442-459.

To cite this abstract in AMA style:

C. Mahapatra. In Silico Electrophysiology and System Pharmacology Reveal Coupling Between Dopamine Receptors and Ca2+ Channels in Subthalamic Neuronal Cells towards Parkinson’s Disease [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/in-silico-electrophysiology-and-system-pharmacology-reveal-coupling-between-dopamine-receptors-and-ca2-channels-in-subthalamic-neuronal-cells-towards-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/in-silico-electrophysiology-and-system-pharmacology-reveal-coupling-between-dopamine-receptors-and-ca2-channels-in-subthalamic-neuronal-cells-towards-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley